183 related articles for article (PubMed ID: 25380420)
1. Landmark approvals in idiopathic pulmonary fibrosis.
Ratner M
Nat Biotechnol; 2014 Nov; 32(11):1069-70. PubMed ID: 25380420
[No Abstract] [Full Text] [Related]
2. Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.
Karimi-Shah BA; Chowdhury BA
N Engl J Med; 2015 Mar; 372(13):1189-91. PubMed ID: 25806913
[No Abstract] [Full Text] [Related]
3. Developments in the management of idiopathic pulmonary fibrosis.
Drug Ther Bull; 2015 Jul; 53(7):78-81. PubMed ID: 26159700
[TBL] [Abstract][Full Text] [Related]
4. The curse of idiopathic.
O'Brien KJ; Gahl WA; Gochuico BR
J Inherit Metab Dis; 2018 Jan; 41(1):3-4. PubMed ID: 29080035
[No Abstract] [Full Text] [Related]
5. Update in diffuse parenchymal lung disease, 2013.
Rosas IO; Kaminski N
Am J Respir Crit Care Med; 2015 Feb; 191(3):270-4. PubMed ID: 25635490
[TBL] [Abstract][Full Text] [Related]
6. Two new drugs for idiopathic pulmonary fibrosis.
Med Lett Drugs Ther; 2014; 56(1457):123-4. PubMed ID: 25461229
[No Abstract] [Full Text] [Related]
7. [Antifibrotic treatment].
von der Beck D; Löh B; Drakopanagiotakis F; Markart P; Günther A
Dtsch Med Wochenschr; 2014 Dec; 139(49):2523-5. PubMed ID: 25423462
[No Abstract] [Full Text] [Related]
8. Therapeutic advances in idiopathic pulmonary fibrosis.
George G; Vaid U; Summer R
Clin Pharmacol Ther; 2016 Jan; 99(1):30-2. PubMed ID: 26502087
[No Abstract] [Full Text] [Related]
9. Two therapies now available for idiopathic pulmonary fibrosis.
Morrow T
Manag Care; 2014 Dec; 23(12):47-8. PubMed ID: 25939185
[No Abstract] [Full Text] [Related]
10. FDA panel likes new treatment for idiopathic pulmonary fibrosis.
Morrow T
Manag Care; 2010 Apr; 19(4):53-4. PubMed ID: 20446566
[No Abstract] [Full Text] [Related]
11. Novel treatments for idiopathic pulmonary fibrosis.
Spagnolo P
Am J Med; 2015 May; 128(5):447-9. PubMed ID: 25613299
[No Abstract] [Full Text] [Related]
12. Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?
Rangarajan S; Locy ML; Luckhardt TR; Thannickal VJ
Drugs; 2016 Mar; 76(3):291-300. PubMed ID: 26729185
[TBL] [Abstract][Full Text] [Related]
13. Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.
Ryerson CJ; Collard HR
Thorax; 2014 Sep; 69(9):791-2. PubMed ID: 24996636
[No Abstract] [Full Text] [Related]
14. InterMune and Boehringer blaze trails for idiopathic pulmonary fibrosis drugs.
Kingwell K
Nat Rev Drug Discov; 2014 Jul; 13(7):483-4. PubMed ID: 24981347
[No Abstract] [Full Text] [Related]
15. [Two new drugs for the treatment of idiopathic lung fibrosis: A new therapeutic era!].
Crestani B
Rev Med Interne; 2015 Nov; 36(11):719-21. PubMed ID: 26065328
[No Abstract] [Full Text] [Related]
16. Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.
Raghu G; Selman M
Am J Respir Crit Care Med; 2015 Feb; 191(3):252-4. PubMed ID: 25635489
[No Abstract] [Full Text] [Related]
17. Design of Idiopathic Pulmonary Fibrosis Clinical Trials in the Era of Approved Therapies.
Kaner RJ; Bajwa EK; El-Amine M; Gorina E; Gupta R; Lazarus HM; Luckhardt TR; Mouded M; Posada K; Richeldi L; Stauffer J; Tutuncu A; Martinez FJ
Am J Respir Crit Care Med; 2019 Jul; 200(2):133-139. PubMed ID: 30985215
[No Abstract] [Full Text] [Related]
18. [The Latest Information on Respiratory Disease Management. Topics: III. New Treatment of Idiopathic Pulmonary Fibrosis].
Kashiwada T; Azuma A
Nihon Naika Gakkai Zasshi; 2016 Jun; 105(6):970-6. PubMed ID: 30168687
[No Abstract] [Full Text] [Related]
19. [Two drugs inhibit disease progression. Idiopathic lung fibrosis treatable for the first time].
Einecke D
MMW Fortschr Med; 2015 Feb; 157(2):24-5. PubMed ID: 25743506
[No Abstract] [Full Text] [Related]
20. [Novel therapies for idiopathic pulmonary fibrosis].
Wand O; Kremer MR
Harefuah; 2015 Jul; 154(7):446-50, 469, 468. PubMed ID: 26380465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
